J Clin Neurol.  2013 Jul;9(3):196-197. 10.3988/jcn.2013.9.3.196.

Sporadic Porphyria Cutanea Tarda in a Patient with Multiple Sclerosis Treated with Interferon Beta 1-a Therapy: A Case Report

• Carrieri P
• Petracca M
• Montella S
• Cerullo G
• Cerillo I
• Cimmino G

• KMID: 2287559
• DOI: http://doi.org/10.3988/jcn.2013.9.3.196

Abstract

No abstract available.

MeSH Terms

Humans
Interferon-beta
Interferons
Multiple Sclerosis
Porphyria Cutanea Tarda
Porphyrias
Interferon-beta
Interferons

Figure

• 

  Fig. 1 A: MRI showing several demyelinating lesions. B: Skin lesions on the back of the patient's hands.

Reference

1. Frank J, Poblete-Gutiérrez P. Porphyria cutanea tarda--when skin meets liver. Best Pract Res Clin Gastroenterol. 2010; 24:735–745.

2. Sarkany RP. The management of porphyria cutanea tarda. Clin Exp Dermatol. 2001; 26:225–232.

3. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011; 69:292–302.

4. Pérez Álvarez R, Pérez López R, González Sotorrío N, Rodrigo Sáez L. Porphyria cutanea tarda with multiple nodular foci in the liver. Gastroenterol Hepatol. 2012; 35:50–52.

5. Grieco A, Alfei B, Di Rocco P, Miele L, Biolcati G, Griso D, et al. Non-alcoholic steatohepatitis induced by carbamazepine and variegate porphyria. Eur J Gastroenterol Hepatol. 2001; 13:973–975.

6. Cassiman D, Vannoote J, Roelandts R, Libbrecht L, Roskams T, Van den Oord J, et al. Porphyria cutanea tarda and liver disease. A retrospective analysis of 17 cases from a single centre and review of the literature. Acta Gastroenterol Belg. 2008; 71:237–242.